Monday, April 28, 2025

Latest

Apple: Consensus Estimates For Q2 2021

Apple (NASDAQ: AAPL) will be reporting their fiscal second quarter on April 28th after market close. Analysts have a consensus $152 12-month price target on the company, via a total of 40 analysts, with 11 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 6 have hold ratings, one analyst has a sell rating, and one has a strong sell on the company. The street high comes from Evercore ISI with a $175 price target, and the lowest target sits at $83.

27 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 27 analysts is $76.87 billion; this number has been revised upwards from $74 billion at the start of the year. The highest revenue estimate is $83.2 billion, while the lowest is $70.9 billion.

Onto EBITDA estimates, there are currently only 10 analysts who have second-quarter EBITDA estimates. The mean is currently $22.5 billion, with this number having been revised down from $20.2 billion at the start of the year. Street high is a $23.9 billion EBITDA estimate and the lowest is $20.3 billion.

Analysts estimate that quarterly earnings per share will come in at $0.98, with this number being slightly revised up from $0.90 at the start of the year. Street high is currently $1.09 and the lowest estimate is $0.85 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Stifel: “We View Green Thumb As The Best In Class Operator in US Cannabis”

Last week, Stifel GMP released their top picks for the fourth quarter of 2020, headlining...

Monday, October 19, 2020, 12:58:00 PM

Curaleaf: The Analyst Take On The European Expansion

On April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of...

Friday, April 9, 2021, 11:46:00 AM

Target: Analyst Consensus First Quarter Estimates

Target Corporation (NYSE: TGT) will be reporting their first-quarter financial results May 19th before market...

Tuesday, May 18, 2021, 06:29:00 PM

Cameco Sees Canaccord Cut Price Target To $43

Cameco (TSX: CCO) last week reported its first-quarter financial results, where it showcased strong year-over-year...

Monday, May 9, 2022, 03:11:00 PM

Cresco Labs: Canaccord Lowers Target On Adjusted EBITDA Miss

On August 13, Cresco Labs (CSE: CL) announced its second quarter financials. The company had...

Thursday, August 19, 2021, 11:36:00 AM